Crescita Therapeutics Inc. (TSX:CTX)

Crescita Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.58	9.27	9.39	8.24	11.33
Cash & Short-Term Investments	8.58	9.27	9.39	8.24	11.33
Cash Growth	-7.51%	-1.19%	13.92%	-27.30%	-20.66%
Accounts Receivable	1.84	1.36	1.19	4.56	2.11
Inventory	4.72	4.05	6.13	5.65	4.39
Other Current Assets	0.24	0.23	1.56	1.58	1.5
Total Current Assets	15.72	15.3	18.49	20.52	20.09
Net Property, Plant & Equipment	1.79	2.42	1.85	2.31	2.58
Other Intangible Assets	1.46	1.74	1.99	2.87	3.74
Long-Term Investments	-	0.93	0.79	0.77	0.85
Other Long-Term Assets	1.36	1.39	1.48	2.03	1.66
Total Assets	20.33	21.78	24.6	28.48	28.92
Accounts Payable	4.34	5	4.33	5.6	5.33
Short-Term Debt	-	-	-	-	0.98
Current Portion of Leases	0.33	0.47	0.44	0.41	0.37
Other Current Liabilities	0.05	0.05	0.1	0.05	0.05
Total Current Liabilities	4.72	5.52	4.86	6.06	6.73
Long-Term Leases	-	0.37	0.82	1.21	1.53
Other Long-Term Liabilities	0.03	0.07	0.1	0.12	0.15
Total Long-Term Liabilities	0.03	0.43	0.91	1.33	1.67
Total Liabilities	4.75	5.95	5.78	7.39	8.4
Common Stock	51.49	52.7	54.34	56.3	58.08
Additional Paid-in Capital	8.41	7.37	5.96	4.27	2.77
Accumulated Other Comprehensive Income	1.12	1.11	1.12	1.13	1.15
Retained Earnings	-45.44	-45.35	-42.6	-40.61	-41.48
Shareholders' Equity	15.58	15.83	18.82	21.1	20.53
Total Liabilities & Equity	20.33	21.78	24.6	28.48	28.92
Total Debt	0.33	0.83	1.25	1.61	2.87
Net Cash (Debt)	8.24	8.44	8.13	6.63	8.46
Net Cash Growth	-2.32%	3.79%	22.73%	-21.72%	-35.15%
Net Cash Per Share	0.44	0.44	0.40	0.32	0.41
Book Value	15.58	15.83	18.82	21.1	20.53
Book Value Per Share	0.83	0.82	0.93	1.00	0.99
Tangible Book Value	14.12	14.09	16.83	18.23	16.79
Tangible Book Value Per Share	0.75	0.73	0.83	0.87	0.81

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.